Abstract
Botulinum neurotoxin A (BoNT-A) is a useful medication for the reduction of muscle overactivity in the upper limb(s) of children with cerebral palsy. The method for BoNT-A delivery, dose, and muscle localization criteria are established. Children who are being treated require appropriate assessment at the impairment and activity levels of functioning. Once injected, children require specific therapy delivered by an occupational therapist according to the specified goals that are set out prior to injection, by the child, family, and health-care workers. BoNT-A injection offers the child with cerebral palsy a period of reduced muscle overactivity and is a useful adjunct to evidence-based upper-limb therapy.
Keywords
After injection and intensive therapy, the client was really happy to be able to catch and throw a ball with his school friends.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACPR (2013) Australian cerebral palsy register group: Australian cerebral palsy register report 2013 birth years 1993 to 2006. Cerebral Palsy Institute. http://www.cpresearch.org.au/pdfs/2013_ACPR-Report_Webpdf. Accessed 17 Oct 2010
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B et al (2005) Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 47(8):571–576
Bohannon RW, Smith MB (1987) Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67(2):206–207
Boyd RN, Graham HK (1999) Objective measurement of clinical finding in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 6(Suppl 4):S23–S35
Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6:S146–S168
Chapparo C, Ranka J (1997) Occupational performance model (Australia), (vol Monograph 1). OP Network-Total Print Control, Sydney
Chin TY, Nattrass GR, Selber P, Graham HK (2005) Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25(3):286–291
Davids JR, Peace LC, Wagner LV, Gidewall MA, Blackhurst DW, Roberson WM (2006) Validation of the Shriners Hospital for Children Upper Extremity Evaluation (SHUEE) for children with hemiplegic cerebral palsy. J Bone Joint Surg Am 88(2):326–333
Eliasson AC (2005) Improving the use of hands in daily activities: aspects of the treatment of children with cerebral palsy. Phys Occup Ther Pediatr 25(3):37–60
Eliasson AC, Krumlinde-Sundholm L, Rosblad B, Beckung E, Arner M, Ohrvall AM et al (2006) The manual ability classification system (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 48(7):549–554
Eliasson A-C, Krumlinde-Sundholm L, Gordon A, Feys H, Klingels K, Aarts P, Hoare B (2014) Guidelines for future research in constraint-induced movement therapy for children with unilateral cerebral palsy: an expert consensus. Dev Med Child Neurol 56:125–137
Elvrum A-KG, Braendvik SM, Sæther R, Lamvik T, Vereijken B, Roeleveld K (2012) Effectiveness of resistance training in combination with botulinum toxin-A on hand and arm use in children with cerebral palsy: a pre-post intervention study. BMC Pediatr 12(1):91
Faigenbaum A, Kraemer W, Blimkie C, Jeffreys I, Micheli LJ, Nitka M, Rowland TW (2009) Youth resistance training: updated position statement paper from the national strength and conditioning association. J Strength Cond Res 23(Suppl 5):S60–S79
Fehlings D, Novak I, Berweck S, Hoare BJ, Stott NS, Russo RN (2010) Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol 17(Suppl 2):38–56
Forrester M, Srinivasan J, Mihrshahi S, Waugh M, O’Flaherty S, Rice J, Graham K, Scheinberg A (2011) Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children—A two centre cross-sectional prospective audit. Eur J Paediatr Neurol 16(2):1–3
Graham HK (2000) Botulinum toxin A in cerebral palsy: functional outcomes. J Pediatr 137(3):300–303
Hoare BJ, Wasiak J, Imms C, Carey L (2007) Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst Rev (2) CD004149
Hoare BJ, Imms C (2009) Getting Ready for School. In: Dodd K, Imms C, Taylor N, editors. Physical and Occupational Therapy for Cerebral Palsy. London: McKeith Press
Hoare BJ, Imms C, Rawicki HB, Carey L (2010) Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper. BMC Neurol 10:58
Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L (2010) Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Sys Rev (Online)(1) CD003469
Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L (2013) Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial. Dev Med Child Neurol 55(3):238–247
Jackman M, Novak I, Lannin N (2013) Effectiveness of hand splints in children with cerebral palsy: a systematic review with meta-analysis. Dev Med Child Neurol 56:138–147
Jankovic J, Brin MF (1997) Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 6:S129–S145
Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D (2010) Development of the hypertonia assessment tool (HAT): a discriminative tool for hypertonia in children. Dev Med Child Neurol 52(5):e83–e87
Jongbloed-Pereboom M, Nijhuis-van der SMW, Steenbergen B (2013) Norm scores of the box and block test for children ages 3–10 years. Am J Occup Ther 67(3):312–318
Kanellopoulos AD, Mavrogenis AF, Mitsiokapa EA, Panagopoulos D, Skouteli H, Vrettos SG, Tzanos G, Papagelopoulos PJ (2008). Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children. Eur J Phys Rehabil Med 45(4):501–506
Kaplan MT, Bedell G (1999) Motor skill acquisition frame of reference. In: Kramer P, Hinojosa J (eds) Frames of reference for pediatric occupational therapy, 2nd edn. Williams and Wilkins, Baltimore, pp 401–429
Katalinic MO, Harvey LA, Herbert RD, Moseley AM, Lannin NA, Schurr K (2009) Stretch for the treatment and prevention of contractures. Cochrane Database Syst Rev (Online)(9) CD007455–CD007455
Kielhofner G (1995) A model of human occupation. Theory and application, 2nd edn. Williams and Wilkins, Baltimore
Kiresuk TJ, Smith JE, Cardillo JE (1994) Goal attainment scaling: applications, theory and measurement. Lawrence Erlbaum, Hillsdale
Krumlinde-Sundholm L, Holmefur M, Kottorp A, Eliasson AC (2007) The assisting hand assessment: current evidence of validity, reliability, and responsiveness to change. Dev Med Child Neurol 49(4):259–264
Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N (1994) The Canadian occupational performance measure, 2nd edn. Canadian Association of Occupational Therapists, Toronto
Law M, Stanton S, Polatajko H, Baptiste S, Thompson-Franson T, Kramer C et al (1997) Enabling occupation: an occupational therapy perspective. CAOT Publications, Ottawa
Mandich AD, Polatajko HJ, Macnab JJ, Miller LT (2000) Treatment of children with developmental coordination disorder: what is the evidence? Phys Occup Ther Pediatr 20(2–3):51–68
Mastos M, Miller K, Eliasson AC, Imms C (2007) Goal-directed training: linking theories of treatment to clinical practice for improved functional activities in daily life. Clin Rehabil 21(1):47–55
Mockford M, Caulton J (2010) The pathophysiological basis of weakness in children with cerebral palsy. Pediatr Phy Ther 22(2):222–233
Muratori LM, Lamberg EM, Quinn L, Duff SV (2012) Applying principles of motor learning and control to upper extremity rehabilitation. J Hand Ther 26(2):94–103
Novak I, Cusick A, Lannin N (2009) Occupational therapy home programs for cerebral palsy: double-blind, randomized, controlled trial. Pediatrics 124(4):e606–e614
Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, et al (2013) A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med and Child Neurol 55(10):885–910
Randall M, Imms C, Carey L (2012) Further evidence of validity of the modified Melbourne assessment for neurologically impaired children aged 2 to 4 years. Dev Med Child Neurol 54(5):424–428
Russman BS, Tilton A, Gormley ME Jr (1997) Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve Suppl 6:S181–S193
Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E (2007) Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics 119(5):e1149–e1158
Stackhouse S, Binder-Macleod S, Lee S (2005) Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy. Muscle Nerve 31:594–601
Tardieu C, Lespargot A, Tabary C, Bret MD (1988) For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 30(1):3–10
Taub E, Uswatte G, Pidikiti R (1999) Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation-a clinical review. J Rehabil Res Dev 36(3):237–251
Wallen M, O’Flaherty SJ, Waugh MC (2007) Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. Arch Phys Med Rehabil 88(1):1–10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
The Case Study of Anna: Activity-based Therapy Following Upper-Limb Injections of Botulinum Neurotoxin A
Keywords
Botulinum neurotoxin A, cerebral palsy, upper-limb rehabilitation
Introduction
The theme of this case study is to improve the functional use of the more affected upper limb in a young child with unilateral cerebral palsy.
The student’s tasks include:
-
Understanding the etiology, definition, types, and symptoms of cerebral palsy (Bax et al. 2005)
-
Reasons for using botulinum neurotoxin A in the upper limb in children with cerebral palsy (Hoare et al. 2010; Hoare et al. 2013)
-
Understanding the types and evidence for upper-limb occupational therapy intervention in children with cerebral palsy (Valvano 2004; Novak et al. 2013; Eliasson et al 2013)
-
Synthesizing the information into a report
As a starting point, students should use the following references to gather background information.
Important references include:
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B et al (2005) Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 47(8):571–576
Eliasson A-C, Krumlinde-Sundholm L, Gordon A, Feys H, Klingels K, Aarts P, Rameckers E, Autti-Rämö I, Hoare B (2013) Guidelines for future research in Constraint-induced movement therapy for children with unilateral cerebral palsy: An expert consensus. Dev Med Child Neurol (in Press)
Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L (2010) Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Sys Rev (Online)(1) CD003469
Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L (2013) Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial. Dev Med Child Neurol 55(3):238–247
Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, Stumbles E, Wilson SA, Goldsmith S (2013) A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol 55(10):885–910
Valvano J (2004) Activity-focused motor interventions for children with neurological conditions. Phys Occup Ther Pediatr 24(1–2):79–107
Overview of the Content
Major Goals of the Actual Intervention
The major goal for injection of botulinum neurotoxin A is to reduce muscle overactivity thereby reducing the risk for development of increased muscle stiffness and permanent muscle shortening. As an adjunct to upper-limb activity-based intervention, injection of BoNT-A also offers a window of reduced muscle overactivity and improved posture to maximize the effect of activity-based therapy that aims to improve upper-limb function and occupational performance.
Learning Objectives
By the end of studying this chapter, the learner will:
-
Be able to use a literature review to solve the case based on the CM
-
Be able to apply the CM in clinical reasoning to the specific case study and similar clinical situations.
-
Understand the justification and ethical considerations related to using botulinum neurotoxin A in children with cerebral palsy.
-
Write a scientific report on using botulinum neurotoxin A as an adjunct to upper-limb therapy in children with cerebral palsy.
The background history of the clinical case study:
Personal Information
Anna is an 18-month-old girl who lives with her parents, James and Kate. James works full time and Kate works 3 days a week. While her parents are working, Anna attends child-care for 2 days a week and is cared for by her maternal grandparents on the other day.
Medical Information Including Prognoses
Anna was born at term via an uncomplicated pregnancy. At 4 months of age, Kate noticed that Anna’s right hand was fisted with her thumb tucked into the palm. Anna also had a strong left-hand preference during play and avoided use of her right hand. At 7 months of age, Anna was assessed by a pediatric neurologist who suspected a diagnosis of right unilateral cerebral palsy . This was confirmed by an MRI at 8 months of age. Anna now sits independently and uses a commando crawl to move around on the floor. She does not crawl. She has recently started to pull to stand and is able to take steps while holding onto furniture. She has started to use single words and responds well to verbal cues.
Occupational Therapy Interventions
Following her diagnosis, Anna was referred to the physical rehabilitation clinic at a local hospital. She was assessed by the multidisciplinary team and goals discussed with her parents. James and Kate were very concerned about Anna’s lack of spontaneous use of her right upper limb and their primary goal was for Anna to play with toys using two hands. As a result, Anna received an 8-week block of modified constraint-induced movement therapy (mCIMT) with her occupational therapist. She was also provided with a static overnight stretching splint with a supination strap. Anna made significant improvements following mCIMT. She now spontaneously initiates the use of her right hand to touch and hold objects. She is able to grasp, hold, transport, and release smaller objects but has difficulty with larger objects. She also has difficulty stabilizing objects on the table and pulling objects apart. Anna has full passive range of motion in all joints and no catch is present on high-velocity passive stretch. During her post-intervention assessment, Anna’s occupational therapist was concerned with increasing abnormal posture in her right shoulder, forearm, and thumb. During active use of the right upper limb, Anna’s shoulder appeared to internally rotate, the forearm hyper-pronated, and thumb adducted across her palm. This made the effective grasp of objects difficult. The occupational therapist felt an injection of botulinum neurotoxin A would assist in improving posture during active use of the limb and an appointment was made for consultation with the rehabilitation specialist at the physical rehabilitation clinic.
The Student’s Report
The following guiding questions have been identified in developing possible solutions for Anna. These questions were generated from the references found in the literature search:
-
What are the major definitions and concepts used in this case?
-
What is the aim of the static night splint with supination strap?
-
Is Anna an appropriate candidate for upper-limb botulinum neurotoxin A? What valid and reliable assessments could be used to help determine the need of an upper-limb injection?
-
What muscles would be considered for injection of botulinum neurotoxin A?
-
What type of activity level intervention would be appropriate for Anna following injection of BoNT-A? What intensity and how long should this intervention be provided for? What is the evidence for this intervention?
-
What are some examples of age-appropriate and challenging activities to use in therapy sessions?
-
What are some considerations for the treatment environment to ensure Anna achieves the level of practice required to improve her hand skills?
-
What are some of the personal and environmental barriers to implementing a home program for Anna?
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hoare, B., Russo, R. (2015). Upper-Limb Therapy in Children Following Injection of Botulinum Neurotoxin A. In: Söderback, I. (eds) International Handbook of Occupational Therapy Interventions. Springer, Cham. https://doi.org/10.1007/978-3-319-08141-0_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-08141-0_45
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08140-3
Online ISBN: 978-3-319-08141-0
eBook Packages: MedicineMedicine (R0)